01 1North China Pharmaceutical Huasheng Co Ltd
01 1TACROLIMUS USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-04-02
Pay. Date : 2021-03-19
DMF Number : 34270
Submission : 2020-03-25
Status : Active
Type : II
20
North China Pharmaceutical Huasheng Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TACROLIMUS USP, with a corresponding US DMF Number 34270.
Remarkably, this DMF maintains an Active status since its submission on March 25, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 02, 2021, and payment made on March 19, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
